Informatie:
Fout:
ID
15642
Beschrijving
Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential (ALAIN01) https://clinicaltrials.gov/ct2/show/NCT02419378 Principal Investigator Prof. Dr. Dr. Sven Meuth, University Hospital Muenster, Germany Part: Relapse Evaluation Visit No. 1
Link
https://clinicaltrials.gov/ct2/show/NCT02419378
Trefwoorden
Versies (3)
- 8/13/15 8/13/15 - Martin Dugas
- 5/28/16 5/28/16 -
- 6/6/16 6/6/16 -
Geüploaded op
June 6, 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Relapse Evaluation Visit No. 1: Relapse Confirmation Multiple Sclerosis ALAIN01 NCT02419378
Relapse Evaluation Visit No. 1: Relapse Confirmation Relapse Multiple Sclerosis ALAIN01 NCT02419378
Similar models
Relapse Evaluation Visit No. 1: Relapse Confirmation Relapse Multiple Sclerosis ALAIN01 NCT02419378
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Patient ID (derived)
Item
Patient ID (derived)
text
C2348585 (UMLS CUI [1])
Relapse confirmed
Item
Relapse confirmed yes/no
boolean
C0277556 (UMLS CUI [1,1])
C0750484 (UMLS CUI [1,2])
C0750484 (UMLS CUI [1,2])
Recurrence date
Item
Date of Relapse
date
C0807712 (UMLS CUI [1])
Corticosteroid therapy
Item
Relapse: Corticosteroid therapy yes/no
boolean
C0149783 (UMLS CUI [1])
Relapse: Date of Signature
Item
Relapse: Date of Signature
date
C1519316 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])